Mizacorat

米萨科拉特

Mizacorat

M656113-1ml

1ml

10mM in DMSO

-80℃储存

超低温冰袋运输

Mizacorat (AZD9567; compound 15) is a potent, oral active, non-steroidal and selective glucocorticoid receptor modulator (SGRM) , with an IC 50 of 3.8 nM. Exhibits excellent efficacy in the streptococcal cell wall (SCW) reactivation model of joint inflammation In Vivo Mizacorat (15 mg/kg/day, Oral gavage daily for 8 days) treatment shows excellent in vivo efficacy in a rat model of joint inflammation . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Antigen-induced joint inflammation model in female Lewis rats (175-200 g), sensitized by an intra-articular injection of 5 μg of SCW . Dosage: 15 mg/kg/day. Administration: Oral gavage daily for 8 days. Result: Inhibited ankle swelling in the rat SCW model. IC50& Target:IC50: 3.8 nM (Glucocorticoid receptor)

Mizacorat（AZD9567；化合物 15）是一种强效的口服活性非甾体选择性糖皮质激素受体调节剂（SGRM），IC 50 为 3.8 nM。在链球菌细胞壁（SCW）再活化关节炎模型中表现出卓越的疗效

1893415-00-3(DMSO)

C27H28F2N4O3

494.53 g/mol

CC(C)C(C(C1=CC=CC=C1)OC2=CC3=C(C=C2)N(N=C3)C4=CN(C(=O)C=C4)C)NC(=O)C(C)(F)F